Chen Yuhui, Tian Jun, Chi Bin, Zhang Shangming, Wei Liangfeng, Wang Shousen
Department of Neurosurgery, 900th Hospital, Fuzong Clinical Medical College of Fujian Medical University, Fuzhou 350025, China.
J Clin Med. 2021 Dec 30;11(1):185. doi: 10.3390/jcm11010185.
The incidence of coagulopathy after open traumatic brain injury (TBI) is high. Coagulopathy can aggravate intracranial hemorrhage and further increase morbidity and mortality. The purpose of this study was to determine the clinical characteristics of coagulopathy after open TBI and its relationship with the prognosis.
This study retrospectively evaluated patients with isolated open TBI from December 2018 to December 2020. Coagulopathy was defined as international normalized ratio (INR) > 1.2, activated thromboplastin time (APTT) > 35 s, or platelet count <100,000/μL. We compared the relationship between the clinical, radiological, and laboratory parameters of patients with and without coagulopathy, and the outcome at discharge. Logistic regression analysis was used to evaluate the risk factors associated with coagulopathy. We then compared the effects of treatment with and without TXA in open TBI patients with coagulopathy.
A total of 132 patients were included in the study; 46 patients developed coagulopathy. Patients with coagulopathy had significantly lower platelet levels (170.5 × 10/L vs. 216.5 × 10/L, < 0.001), and significantly higher INR (1.14 vs. 1.02, < 0.001) and APTT (30.5 s vs. 24.5 s, < 0.001) compared to those with no coagulopathy. A Low Glasgow Coma Scale (GCS) score, high neutrophil/lymphocyte ratio (NLR), low platelet/lymphocyte ratio (PLR), and hyperglycemia at admission were significantly associated with the occurrence of coagulopathy.
Coagulopathy often occurs after open TBI. Patients with a low GCS score, high NLR, low PLR, and hyperglycemia at admission are at greater risk of coagulopathy, and therefore of poor prognosis. The efficacy of TXA in open TBI patients with coagulopathy is unclear. In addition, these findings demonstrate that PLR may be a novel indicator for predicting coagulopathy.
开放性创伤性脑损伤(TBI)后凝血病的发生率很高。凝血病会加重颅内出血,并进一步增加发病率和死亡率。本研究的目的是确定开放性TBI后凝血病的临床特征及其与预后的关系。
本研究回顾性评估了2018年12月至2020年12月期间孤立性开放性TBI患者。凝血病定义为国际标准化比值(INR)>1.2、活化部分凝血活酶时间(APTT)>35秒或血小板计数<100,000/μL。我们比较了有凝血病和无凝血病患者的临床、影像学和实验室参数之间的关系,以及出院时的结局。采用逻辑回归分析评估与凝血病相关的危险因素。然后我们比较了在有凝血病的开放性TBI患者中使用和不使用氨甲环酸(TXA)治疗的效果。
本研究共纳入132例患者;46例患者发生凝血病。与无凝血病患者相比,凝血病患者的血小板水平显著更低(170.5×10⁹/L对216.5×10⁹/L,P<0.001),INR显著更高(1.14对1.02,P<0.001),APTT显著更高(30.5秒对24.5秒,P<0.001)。入院时格拉斯哥昏迷量表(GCS)评分低、中性粒细胞/淋巴细胞比值(NLR)高、血小板/淋巴细胞比值(PLR)低和血糖高与凝血病的发生显著相关。
凝血病常发生于开放性TBI后。入院时GCS评分低、NLR高、PLR低和血糖高的患者发生凝血病的风险更大,因此预后较差。TXA在有凝血病的开放性TBI患者中的疗效尚不清楚。此外,这些发现表明PLR可能是预测凝血病的一个新指标。